Jci_page_head_homepage_01 Jci_page_head_homepage_02
Pranavkumar Shivakumar, Gregg E. Sabla, Peter Whitington, Claire A. Chougnet, Jorge A. Bezerra
Published in Volume 119, Issue 8
J Clin Invest. 2009; 119(8):2281–2290 doi:10.1172/JCI38879
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1
Population and activation of NK cells in livers of infants with biliary atresia.

(A) Representative sections of livers from unaffected controls and from infants at the time of diagnosis of biliary atresia immunostained with anti-cytokeratin (to detect cholangiocytes; green, left panels) and anti-CD56 (to detect NK cells; red, middle panels) antibodies. Right panels represent overlays of left and middle panels after nuclear counterstaining with DAPI (blue). Arrowheads indicate NK cells in the portal tract; arrows indicate NK cells juxtaposed to cholangiocytes; original magnification, ×400. (B) mRNA fold change relative to controls for genes encoding cytotoxic receptors, activation markers, and NKG2D-related genes in livers of infants with biliary atresia. mRNA was quantified by real-time PCR and expressed as a ratio to human HPRT. n = 9 for biliary atresia and n = 7 for controls; fold changes for all genes, except for NCR3 and FCGR3B, are statistically significant (P < 0.05).